Cannabis
With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)
Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)
Why did Texas ban Delta-8? (Popular Science)
Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)
California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)
State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)
The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)
Cannabis is one industry that's actually coming out of Covid even stronger (CNN)
South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)
New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)
Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)
Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)
Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)
Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)
Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)
Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)
LSD
Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)
Magic Mushrooms
Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)
Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)
Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)
Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)
More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)
MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)
Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)
MDMA
No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)
MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)
Ayahuasca
Des Moines church fights IRS over ‘religious’ use of hallucinogenic drug (Iowa Capital Dispatch)
5-MeO-DMT
Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)
Novel Psychoactive Substances
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)
Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)
Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)
Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)
Synthetic Cannabinoids
The Dangers of 'Spice' and Other Synthetic Cannabinoids (Discover Magazine)
Ketamine
European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)
Cocaine, ketamine use on the rise: survey (PerthNow)
Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)
Miscellaneous
Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)
Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)
Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)
Addressing Abuse in Psychedelic Spaces (Psychedelics Today)
North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)
Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)
Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)
How Gender Affects the Way We Use Drugs (TalkingDrugs)
DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)
MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)
Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)
Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)
Psychedelic Research Beyond Depression & Trauma (Truffle Report)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.